These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15207740)

  • 1. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures.
    Igarashi K; Hirotani H; Woo JT; Stern PH
    Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enamel matrix derivative promotes osteoclast cell formation by RANKL production in mouse marrow cultures.
    Otsuka T; Kasai H; Yamaguchi K; Nishihara T
    J Dent; 2005 Oct; 33(9):749-55. PubMed ID: 16199283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms.
    Granholm S; Lundberg P; Lerner UH
    J Endocrinol; 2007 Dec; 195(3):415-27. PubMed ID: 18000304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
    Miyazaki M; Fujikawa Y; Takita C; Tsumura H
    Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA
    Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
    Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
    J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
    Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
    J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
    Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K
    Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
    Kanno S; Hirano S; Kayama F
    Toxicology; 2004 Oct; 203(1-3):211-20. PubMed ID: 15363596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.
    Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG
    Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture.
    Takahashi E; Mukohyama H; Aoki K; Duarte WR; Lerner UH; Ohya K; Omura K; Kasugai S
    J Med Dent Sci; 2002 Dec; 49(4):109-20. PubMed ID: 12641381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix.
    Otsuka E; Kato Y; Hirose S; Hagiwara H
    Endocrinology; 2000 Aug; 141(8):3006-11. PubMed ID: 10919289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
    Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
    Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
    Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA
    Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
    Lee SK; Goldring SR; Lorenzo JA
    Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NFKappa-B ligand (RANKL).
    Suzuki T; Suda N; Ohyama K
    J Bone Miner Metab; 2004; 22(3):185-91. PubMed ID: 15108059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled RANK induces osteoclastogenesis ligand-independently.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.